US Patent 11912776 Chimeric antigen receptors targeting B-cell maturation antigen
Patent 11912776 was granted and assigned to Pfizer on February, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11912776 Chimeric antigen receptors targeting B-cell maturation antigen
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
